REVB · Revelation Biosciences, Inc.
$1.14
+0.02 (+1.79%)
At close · Aug 7
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company does not anticipate that its current cash and cash equivalents balance will be sufficient to sustain operations within one year after the date that the Company's unaudited condensed financial statements for June 30, 2026 were issued, which raises substantial doubt about its ability to continue as a going concern.”View the 10-Q filed Aug 6, 2026
Market Cap
$4.54M
Shares
3.98M
Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.
The Jun 30, 2026 filing window is
still open — showing the latest known positions. Funds that have not filed yet
carry their prior-quarter positions; a fund that filed without this stock counts
as sold out. Each fund's Change is measured against its own
previous reported quarter, shown in the Reported column. Pick a
completed quarter in the Quarter selector below to put every
fund on one quarter and see the stock-wide activity breakdown.
Holders: 18
Total Value: $599,590
Total Shares: 1,322,589
Institutional Ownership Trend
19 quarters
Holder Concentration
Across 21 13F filersTop Holder
64.7%
of institutional value
Top 5
98.1%
of institutional value
Top 10
100.0%
of institutional value
HHI
4,668
Highly concentrated